Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12200428 | 0.88 | CYP1A2 (0.43) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL24472998 | 0.87 | ALDH1A1 (0.44) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL24473015 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL20624290 | 0.87 | CYP1A2 (0.45) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL17995337 | 0.86 | CYP1A2 (0.42) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL12200479 | 0.85 | L3MBTL1 (0.47) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL25668571 | 0.85 | ALDH1A1 (0.49) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL23759455 | 0.85 | ALDH1A1 (0.45) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL12200448 | 0.85 | CYP1A1 (0.41) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 | |
| SCHEMBL16521876 | 0.85 | CYP1A2 (0.46) | ALDH1A1HPGDMAPTL3MBTL1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| WO-2010067894-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | TERT, CYP1A1, NR2E3 | ALDH1A1 44/4885HPGD 2320/4885MAPT 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.